Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
OPERATING ACTIVITIES:
Consolidated net (loss) income	$ (664,941)	$ 129,329
Adjustments to reconcile consolidated net (loss) income to Net cash provided by operating activities:
Depreciation and amortization	233,012	196,422
Share-based compensation	23,150	31,258
Amortization of debt issuance costs and premium / discount	23,670	27,336
Provision for bad debts	1,713	2,208
Deferred income taxes	(343,815)	8,191
Net loss on disposal of property, plant and equipment	1,091	2,272
Loss on extinguishment of debt	31,712	11,312
Asset impairment charges	0	46,994
Gain on sale of business and other assets	(2,868)	(2,665)
Changes in assets and liabilities which (used) provided cash:
Accounts receivable	(143,857)	9,749
Inventories	84,156	(59,690)
Prepaid and other assets	29,656	(1,939)
Accounts payable	(132,052)	(140,763)
Accrued expenses	770,653	(173,890)
Other liabilities	397,227	174,116
Income taxes payable/receivable	(76,303)	12,232
Net cash provided by operating activities	232,204	272,472
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(57,300)	(54,349)
Proceeds from sale of property, plant and equipment	174	1,553
Acquisitions, net of cash acquired	(1,052,599)	(3,645)
Proceeds from sale of marketable securities	85,105	0
Proceeds from notes receivable, net	24,216	0
Patent acquisition costs and license fees	(5,000)	(10,000)
Proceeds from sale of business, net	54,521	(700)
Proceeds from / (payments to) settlement escrow	11,518	(54,500)
Increase in restricted cash and cash equivalents	(215,267)	0
Decrease in restricted cash and cash equivalents	770,000	0
Other investing activities	5,789	(5,348)
Net cash used in investing activities	(378,843)	(126,989)
FINANCING ACTIVITIES:
Proceeds from issuance of 2023 Notes	750,000	0
Proceeds from issuance of term loans	1,525,000	0
Principal payments on term loans	(1,418,769)	(134,688)
Principal payments on other indebtedness, net	(2,407)	(1,906)
Repurchase of convertible senior subordinated notes due 2015	(587,803)	0
Payments to settle common stock warrants	(284,454)	0
Proceeds from the settlement of the hedge on convertible senior subordinated notes due 2015	356,265	0
Deferred financing fees	(59,899)	(8,129)
Payment for contingent consideration	0	(5,000)
Tax benefits of share awards	30,126	8,415
Payments of tax withholding for restricted shares	(23,920)	(8,284)
Exercise of options	36,124	83,743
Payments related to the issuance of ordinary shares	(4,800)	0
Issuance of ordinary shares related to the employee stock purchase plan	3,468	4,117
Cash distributions to noncontrolling interests	(6,144)	(36,709)
Cash buy-out of noncontrolling interests, net of cash contributions	(82)	(2,032)
Net cash provided by (used in) financing activities	312,705	(100,473)
Effect of foreign exchange rate	(1,547)	1,159
NET INCREASE IN CASH AND CASH EQUIVALENTS	164,519	46,169
LESS: NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS OF DISCONTINUED OPERATIONS	(17,413)	530
NET INCREASE IN CASH AND CASH EQUIVALENTS OF CONTINUING OPERATIONS	181,932	45,639
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	526,597	529,689
CASH AND CASH EQUIVALENTS, END OF PERIOD	708,529	575,328
SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Purchases of property, plant and equipment financed by capital leases	578	461
Accrual for purchases of property, plant and equipment	5,985	3,946
Acquisition financed by ordinary shares	2,844,279	0
Repurchase of convertible senior subordinated notes due 2015 financed by ordinary shares	$ 55,229	$ 0